A floppy disk, a basement phone bank and one C$180,000 laser became a Vancouver clinic built on repeat visits, relentless training and an oddly smart perk: child care while you get treated.
Its products sit in pharmacies, dental offices, GI clinics and aesthetics practices across roughly 100 countries. The hard part is not selling medicine - it is turning a sprawling acquisition legacy into a focused healthcare company before debt, patents and price controls set the pace.
Two Harvard MBAs sketched a med-spa roll-up between squash matches. Six years later, Aesthetic Partners runs the back office for 20-plus clinics - and lets every founder keep their name on the door.
United Aesthetics Alliance is assembling a national network of plastic surgery practices and medical spas without turning them into a single chain. Its wager is that shared capital, recruiting, marketing, and technology can scale - while clinical judgment and local reputations stay local.
Annie Aesthetic is a medical-aesthetics holding company that partners with and acquires leading medical spas across the United States. Incubated by Tucker's Farm Corporation in May 2022 with roughly $30 million of equity capital, it provides its partner clinics with growth capital, operations, marketing, recruiting, technology and legal/regulatory support while keeping founders and operating teams in place. By late 2025 the platform had grown to about $65 million of revenue across 12 medical-aesthetics brands, backed by InterAlpen Partners, Brookside Equity Partners and Plexus Capital.
AVAVA, Inc. is a Waltham, Massachusetts medical aesthetics company that builds energy-based laser platforms for skin renewal that work across all skin tones. Spun out of Boston-based Blossom Innovations and rooted in research from Massachusetts General Hospital's Wellman Center for Photomedicine, AVAVA's flagship MIRIA Skin Treatment System pairs patented Focal Point Technology with AI-driven skin visualization to deliver precise, high-energy intradermal treatment for conditions like melasma, hyperpigmentation, and acne scars with minimal downtime.
Fount Bio is a Somerville, Massachusetts life-science company that builds long-lasting hyaluronic acid (HA) matrices directly inside living tissue. Its proprietary Flī-HA platform uses Nobel-Prize-winning bioorthogonal (click) chemistry to deliver HA building blocks that self-assemble in situ into a biostable, high-molecular-weight matrix - overcoming the delivery and degradation barriers that have long forced HA to be injected as pre-formed filler. The lead product, Flī-Derm, is a needle-free liquid for aesthetic dermatology that reduced fine lines and wrinkles in a blinded clinical study and won IMCAS 2024's Innovation of the Year. The tunable platform extends toward ophthalmology, joints, mucosal tissue and women's health.
PatientFi is a healthcare fintech that lets patients pay for elective medical treatments over time through simple monthly payment plans. Its point-of-sale platform partners with medical practices - across plastic surgery, dermatology, dentistry, ophthalmology, fertility and medical spas - to offer instant, soft-credit-check financing so patients can afford care without upfront strain, while practices grow revenue. Headquartered in Irvine, California, the company markets itself as 'The Friendly Way to Pay.'